Phase 3, Open-label Clinical Trial of EB-101 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Clinical trial NCT04227106 · COMPLETED
Trial details
- NCT number
- NCT04227106
- Sponsor
- Abeona Therapeutics, Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-10
- Primary completion
- 2022-10-18
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.